Armata Pharmaceuticals (ARMP) EBIT Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 12.69% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 75.16% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -347.04% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 80.62% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 8.65% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 1.27% |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 1,386.07% |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | -7.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.25% |
| Dec 31, 2025 | -31.16% |
| Sep 30, 2025 | 20.30% |
| Jun 30, 2025 | 42.55% |
| Mar 31, 2025 | 19.92% |
| Dec 31, 2024 | -10.02% |
| Sep 30, 2024 | 5.61% |
| Jun 30, 2024 | -23.73% |
| Mar 31, 2024 | 9.85% |
| Dec 31, 2023 | 7.25% |
| Sep 30, 2023 | -19.87% |
| Jun 30, 2023 | -4.44% |
| Mar 31, 2023 | -29.30% |
| Dec 31, 2022 | -70.77% |
| Sep 30, 2022 | -40.37% |
| Jun 30, 2022 | -48.81% |
| Mar 31, 2022 | -61.45% |
| Dec 31, 2021 | 6.28% |
| Sep 30, 2021 | -9.25% |
| Jun 30, 2021 | -34.99% |
| Mar 31, 2021 | -10.45% |
| Dec 31, 2020 | -47.46% |
| Sep 30, 2020 | 17.03% |
| Jun 30, 2020 | 11.01% |
| Mar 31, 2020 | -43.01% |
| Dec 31, 2019 | -56.62% |
| Sep 30, 2019 | -179.00% |
| Jun 30, 2019 | -81.43% |
| Mar 31, 2019 | -12.64% |
| Dec 31, 2018 | -18.14% |
| Sep 30, 2018 | -225.60% |
| Jun 30, 2018 | 70.65% |
| Mar 31, 2018 | 9.05% |
| Dec 31, 2017 | 80.07% |
| Sep 30, 2017 | 78.10% |
| Jun 30, 2017 | -169.88% |
| Mar 31, 2017 | 25.65% |
| Dec 31, 2016 | -303.54% |
| Sep 30, 2016 | -40.32% |
| Jun 30, 2016 | -38.46% |